Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 67 of 6351
-
New master trial aims to match immunotherapy to each Patient's tumor before surgery
Disease control Recruiting nowMost cancer treatments are developed without knowing whether the drug's targets are actually present in a patient's tumor or whether the patient is likely to benefit from the treatment. In addition, the immune environment surrounding the tumor changes significantly during the cou…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New vaccine aims to shield sickle cell kids from deadly infections
Vaccine Recruiting nowThe purpose of this study is to measure whether PCV21 vaccine (investigational pneumococcal vaccine) is safe and can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) compared with 20vPCV (licensed pneumococcal vaccine) when given as a single dose…
Phase 3 • Sponsor: Sanofi • Aim: Vaccine
Last updated Jun 27, 2026 12:08 UTC
-
New dengue vaccine trial targets older adults and those with chronic illness
Vaccine Recruiting nowDengue fever is caused by an infection with the dengue virus. Vaccination with Dengue Tetravalent Vaccine (TDV) can help prevent dengue fever. Researchers have seen that dengue fever now also happens more often in elderly persons. The main aim of this study is to learn more about…
Phase 3 • Sponsor: Takeda • Aim: Vaccine
Last updated Jun 27, 2026 12:24 UTC
-
New malaria vaccine trial aims to stop recurrent fever
Vaccine Not yet recruitingThis clinical study will evaluate an investigational malaria vaccine called PvCS/Montanide ISA-51 to determine whether it is safe and whether it can protect adults from infection with Plasmodium vivax, one of the main parasites that causes malaria. P. vivax malaria is common in t…
Phase 2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: Vaccine
Last updated Jun 27, 2026 09:00 UTC
-
New Triple-Drug attack on cervical cancer enters final testing
Disease control Recruiting nowResearchers are looking for new ways to treat metastatic cervical cancer. Cervical cancer is cancer in the cervix, the lower part of the uterus (womb). Metastatic means the cancer has spread to other parts of the body. Researchers want to learn about giving the study medicine sa…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New stroke drug aims to cut disability in first 3 hours
Disease control Recruiting nowThe purpose of this study was to evaluate the efficacy of early administration of BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke
Phase 3 • Sponsor: Biocells (Beijing) Biotech Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a single infusion of modified immune cells tame lupus kidney flares?
Disease control Recruiting nowThe purpose of this trial is to evaluate the efficacy and safety of obecabtagene autoleucel (obe-cel) administered once following lymphodepletion in participants with severe, refractory systemic lupus erythematosus (SLE) and active lupus nephritis (LN).
Phase 2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Endometriosis diagnosis without surgery? new study tests protein biomarkers
Diagnosis Recruiting nowEndometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this…
Sponsor: Trio Fertility • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
New study aims to cut Life-Threatening side effects in child leukemia transplants
Disease control Not yet recruitingCurrent therapeutic strategies for high-risk or relapsed ALL patients often involve intensive treatments, including allogeneic hematopoietic stem cell transplantation (HSCT). HSCT remains a cornerstone of therapy, offering curative potential; however, it is associated with consid…
Phase 2/3 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug combo aims to outperform standard immunotherapy in lung cancer
Disease control Not yet recruitingThis study is a randomized, controlled, double-blind, multi-center phase III registration clinical trial, aiming to observe, compare and evaluate the efficacy and safety of HB0025 combined with paclitaxel + carboplatin compared with pembrolizumab combined with paclitaxel + carbop…
Phase 3 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Engineered immune cells take aim at blistering skin disease
Disease control Recruiting nowThis is an investigator-initiated, single-center, single-arm, open-label exploratory clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of autologous CD19 CAR-T cell therapy in patients with refractory pemphigus vulgaris.
Sponsor: Jinbo Chen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy shot could end monthly eye injections for wet AMD
Disease control Recruiting nowThis is a Phase III, randomized, open-label, active-controlled study to evaluate the efficacy and safety of subretinal injection of LX102 in participants with neovascular age-related macular degeneration. The study will evaluate a single subretinal injection of LX102 compared to …
Phase 3 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for hepatitis delta: phase 3 trial of brelovitug launches
Disease control OngoingThis is a Phase 3, global, randomized, open-label, multicenter trial designed to evaluate the safety and efficacy of chronic treatment with brelovitug (BJT-778) for chronic hepatitis delta virus (HDV) infection. The objective of this study is to test the safety and effectiveness …
Phase 3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New weekly shot could help millions shed pounds and control diabetes
Disease control Recruiting nowThe primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on: * Percent change in body weight * Change in hemoglobin A1c (HbA1c)
Phase 3 • Sponsor: Kailera • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a pill delay diabetes in kids? new trial hopes so
Prevention Recruiting nowThe purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to develop T1D. Participation in the study will last up to approximately 5 years.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Nanocell attack: new combo therapy takes on tough pancreatic cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability and overall survival (OS) of E-EDV-D682/GC in combination with gemcitabine and nab-paclitaxel versus gemcitabine and nab-paclitaxel alone in participants with metastatic pancreatic ductal adenocarcinoma (PDAC) w…
Phase 1/2 • Sponsor: Engeneic Pty Limited • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New dual-targeting CAR t therapy takes on hard-to-treat lymphoma in phase 3 trial
Disease control Recruiting nowThis Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma in the second-line setting.
Phase 3 • Sponsor: Lyell Immunopharma, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a drug combo cure hepatitis b in kids? new trial aims to find out
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of entecavir monotherapy versus sequential entecavir plus pegylated interferon α-2b in achieving functional cure in immune-tolerant, HBeAg-positive children aged 3-6 years with chronic hepatitis B virus infection.
Phase 4 • Sponsor: Qing-Lei Zeng • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New monthly shot could stop COVID-19 before it starts
Prevention OngoingThe main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID-19. VYD2311 is a monoclonal antibody that attaches to the virus that causes COVID-19 and helps block it from entering your cells. It is …
Phase 3 • Sponsor: Invivyd, Inc. • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Lab-Grown skin patch could heal wounds in 'Butterfly Children'
Disease control Recruiting nowThis study is being done to find out if a new type of skin graft, called GMEB-SASS, is safe and effective for helping wounds heal in people with RDEB (Recessive Dystrophic Epidermolysis Bullosa). The GMEB-SASS graft contains two types of living skin cells: keratinocytes and fibr…
Phase 1/2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC